New hope for tough blood cancers: first patients test experimental drug

This is an early-stage study to test the safety and find the right dose of a new drug called BL-M08D1 for adults with advanced lymphoid cancers that have come back or stopped responding to standard treatments. Researchers will enroll about 22 participants to see how the body handles the drug and check for any side effects. The main goal is to determine if the drug is safe enough for further testing and to look for early signs that it might help control the cancer.